Sign Up Today and Learn More About Osteal Therapeutics Stock
Invest in or calculate the value of your shares in Osteal Therapeutics or other pre-IPO companies through EquityZen's platform.
Osteal Therapeutics Stock (OSTH)
Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel treatments for orthopedic infections.
About Osteal Therapeutics Stock
Founded
2013
Headquarters
Dallas, TX, US
Industries
Software, Artificial Intelligence, Data and Analytics
Osteal Therapeutics Press Mentions
Stay in the know about the latest news on Osteal Therapeutics
Osteal Therapeutics Announces Positive 12-Month Results from the APEX Clinical Trial Program at the 2024 American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting
globenewswire • Nov 15, 2024
Osteal Therapeutics Announces Positive 12-Month Results from the APEX Clinical Trial Program at the 2024 American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting
morningstar • Nov 15, 2024
Johnson & Johnson Innovation Archives
dallasinnovates • Aug 03, 2024
Dallas Biotech Secures $50M Series D Funding To Combat Rare Hidden Killer in Joint Replacements
dallasinnovates • Aug 03, 2024
Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
finance • Jun 26, 2024
Osteal Therapeutics Management
Leadership team at Osteal Therapeutics
Chief Executive Officer
David Thompson
Founder, Chief Medical Officer
Brian de Beaubien
Join now and verify your accreditation status to gain access to:
- Osteal Therapeutics current valuation
- Osteal Therapeutics stock price
- Available deals in Osteal Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Osteal Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Osteal Therapeutics through EquityZen funds. These investments are made available by existing Osteal Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Osteal Therapeutics stock?
Shareholders can sell their Osteal Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
